Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celentyx is a private UK-based immunology-focused contract research organization that provides bespoke in vitro assay services to pharmaceutical and biotechnology clients. The company specializes in human primary cell and patient-sample based research supporting immuno-oncology, autoimmunity and inflammation, fibrosis, neuroinflammation, and related areas. Its offerings include functional immune-cell assays, tumour microenvironment and tumour-cell killing assays, cytokine and biomarker profiling, CyTOF, flow cytometry, Luminex, imaging, and custom assay development. Celentyx positions itself as a translational immunology partner that helps clients evaluate drug effects in relevant human systems rather than as a developer of its own therapeutics. The business appears active, privately held, and centered on service revenue rather than a traditional internal drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celentyx.